Synta and QuantumLeap Healthcare Collaborative Announce Selection of …

Published March 11, 2014

Synta and QuantumLeap Healthcare Collaborative Announce Selection of …
LEXINGTON, Mass. & SAN FRANCISCO–(BUSINESS WIRE)–Synta Pharmaceuticals Corp. (NASDAQ:SNTA) and QuantumLeap Healthcare Collaborative today announced that Synta's lead drug candidate, the Hsp90 inhibitor ganetespib, has been … The trial was developed …
Read more on Business Wire (press release)

an abiding passion for the 'least of them'
The Jesus Prom is a natural outgrowth of many years of service as an associate minister at the noted Southland Christian Church, a mega church near Lexington. He was …. On Monday night, four days before the most recent Jesus prom in 2012, Brewster …
Read more on KyForward.com

Startup Cerulean Pharma seeking m in IPO
The most recent were Concert Pharmaceuticals Inc., of Lexington, which raised $ 84 million, and Flexion Therapeutics Inc. in Burlington, which raised $ 65 million. They joined Cambridge-based Eleven Biotherapeutics Inc. and Genocea Biosciences Inc., and …
Read more on Boston Globe

Treatment Center Lexington | Drug Rehab Center Lexington | Treatment Center Lexington — http://lexington.alcoholismrecoverycenter.com/ customized addiction treatment programs, group and individual therapy, healthy recreation and physical activit…

Find More Drug Treatment Centers Lexington Information…